Medilink Midlands’ Post

IP and Contracts- Creating value NOT Chaos- The title of my workshop at the Medilink Midlands Innovation Day on October 3rd delivered in 30 minutes...So expect some fast talking! But seriously, this will be a top tips session covering the most common issues and pitfalls we see and how to avoid/mitigate them. See you there I hope!

Next week, our CEO, Dr. Will Briggs, and COO, Dr. Cat Kelly, will be attending the inaugural HLTH Europe event in Amsterdam. HLTH is known for its ability to bring together the health ecosystem, connecting leaders from around the world, including providers, payers, government, pharma, startups, and investors.   Will and Cat will be on the show floor, learning about the latest developments across healthcare, meeting potential partners, and providing insights into the latest innovations from Naitive. 💡 Why meet with us? 🤝 Get insights on how our technology could enhance clinical capabilities in the management of chronic diseases. 🤝 Learn about how opportunistic screening could redefine the care pathways for musculoskeletal health. Are you attending HLTH? Interested in how our approach could improve population health? Let's meet.   #HLTH #PopulationHealth #HealthcareInnovation

Now at #InnovationDublin24 is the “How to Create an Effective Clinical & Medical Strategy” panel session moderated by Fabienne Hirigoyenberry-Lanson, PhD, Senior Consultant at HTI - Healthcare & Technology International:   ●     Chuck Carignan, Executive Chairman, CAIRDAC ●     Franz Bozsak, CEO, Sensome ●     Michel Therin, President, MT2 Consulting Q: How do you create an effective clinical and medical strategy? A: At each and every stage, we have to ask ourselves what evidence we need to convince stakeholders of our value. A: Start early. If you need 10,000 patients to run a clinical trial, you might not be able to fund that as an early-stage start-up. You need to know this up front. Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

Let’s schedule some to chat at SCOPE to discuss why Helios is the right choice to help you enroll subjects quickly, to have access to quality data and to complete your trial quickly.

Great initiative! The synergy between patient participation in research and the tremendous scientific & medical progress we experience today underscores the critical role of patient engagement in shaping the future of healthcare.

🌟 Our CMO & President, Dr. Bobby Green, took the stage at AHIP 2024 yesterday to participate in a dynamic panel discussion on Driving Progress in Value-Based Specialty Care. 🌟 Dr. Green joined Dr. Luz Ramos from Independence Blue Cross and Dr. Jeremy Wigginton, MD, MBA, FAAFP from Capital Blue Cross to delve into innovative strategies for developing successful value-based arrangements in specialty care. The session was an insightful exploration of the challenges, trends and implementation approaches key to designing specialty care programs that optimize outcomes, lower costs and improve patient satisfaction. Read more about the session and clinical insights shared in this Managed Healthcare Executive article: https://lnkd.in/gGT2Cc7B We look forward to participating at #AHIP again next year!

Last day to get your conference giveaways from BCD. Grab a first-aid kit to soothe those conference walking blisters at the Diversity in Clinical Trials Summit. Continued essential conversations this morning about why representation matters to ensure health equity and how intentional collaboration promotes diverse trial participation. Honored to participate in this important event and meet the people moving the needle forward in life sciences. #clinicaltrials #lifesciences #patientengagement #patientcentricity

🌟 Reminder: we are holding a public CICA Lab webinar tomorrow evening! 🌟 Are you a clinician considering our Clinician Incubator Program? This is your chance to get a taste of the impactful content we offer! 📅 Date: Tomorrow, 6th of August ⏰ Time: 7pm - 8:30pm AEST ✍ Register here: https://lu.ma/254fuj50 Healthcare innovation within large organisations can be daunting. You might wonder: - Where to begin? - Who to approach for funding? - How to navigate common roadblocks? Many clinicians face these challenges and often decide not to pursue their innovative ideas. But we need clinicians as innovators driving the solutions to our most pressing healthcare challenges! Join us for a complimentary webinar where you'll learn: - How to secure funding and where to find it. - Strategies to deliver your project quickly and effectively. - Key traits of successful innovators. Don't miss out on this opportunity to learn how to make a difference from within healthcare systems, and gain some insight into what CICA Lab can offer to all burgeoning clinician innovators! 🚀 Register here: https://lu.ma/254fuj50 Richard Macliver Dr Amandeep H. Dr Bi, Mian Dr Louise Schaper Sarah Newby Creative Careers in Medicine Australian Medical Angels LaunchVic Shadowboxer WeGuide DEPT® Digital Health CRC #ClinicianInnovators #Intrapreneurs #HealthcareInnovation

🔥 Blaze a trail with us this May as we head towards Clinical Trials Day! With every step we take, we're lighting the way to new possibilities and new reasons for hope in medical research. 🌟 Today, let's reflect on the groundbreaking work that lights up the darkest challenges in healthcare. Here's to the innovators and the persevering hearts in the field! 💖 . . . . #myAMCR #HeadlandsResearchAMCR #ClinicalTrialsDay #CTD2024 #ClinicalResearchSite #ResearchExcellence #HeadlandsProud #ImprovingHealthcare #MakingADifferenceTogether #ClinicalResearch #ClinicalResearchTrials

Thank you for all your support! After only about half a year since the launch of EP PerMed, we have already reached 1,000 followers on LinkedIn!🥳🎉👏 We are excited to see how EP PerMed and the #PersonalisedMedicine R&I community can improve health outcomes for patients, citizens and society within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches in the coming years. Together we will: ➡️ Place Europe at the forefront of research and innovation by supporting multidisciplinary activities open to international cooperation. ➡️ Translate basic research into clinical applications that make a difference for patients, their families and healthcare professionals. ➡️ Integrate big data and digital health solutions in research and personalised healthcare. ➡️ Strengthen the European healthcare industry and accelerate the uptake of personalised medicine solutions. ➡️ Provide socio-economic evidence of the feasibility of personalised medicine approaches for their uptake by sustainable healthcare systems. ➡️ Develop appropriate ecosystems for the implementation of successful personalised medicine approaches and the swift uptake of relevant innovations by healthcare systems. ➡️ Ensure wide access to advanced personalised medicine intervention approaches for all. ➡️ Establish a European, national and regional network of research and innovation systems dedicated to personalised medicine. ➡️ Fill scientific knowledge gaps, generate evidence and develop guidance and tools in priority areas for the development and deployment of personalised medicine.